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Abstract  
Synbiotics are dietary means of modulating gut microbiota composition and activities. 
This study aimed to investigate the in vitro potential fermentation properties of two 
synbiotic mixtures on human faecal bacteria from healthy persons. The selected 
synbiotics (fructo-oligosaccharide (FOS) (1%) combined with Bifidobacterium lactis 
BB12 or Bifidobacterium lactis HN019 (106 colony-forming units (CFU)/mL)) were 
added to 48-h pH-controlled anaerobic batch cultures reflective of the distal region of 
the human large intestine. Maltodextrin, FOS and the probiotic components were also 
tested alone. Effects upon major groups of the microbiota were monitored during a time 
course by fluorescence in situ hybridisation (FISH). Short-chain fatty acids (SCFA) 
were measured by gas chromatography (GC).  
Quantitative analysis of bacterial populations revealed that there was a significant 
increase (P<0.05) in bifidobacterial numbers in vessels with FOS and the synbiotic 
mixtures compared to the negative control. Levels of Clostridium coccoides–
Eubacterium rectale group significantly increased (P < 0.05) at 8 and 24 h of 
fermentation with maltodextrin, whereas Atopobium cluster increased after 8 h of FOS 
fermentation. 
Additionally, vessels containing carbohydrates promoted shifts in the production of 
SCFA. Fermentation of FOS and synbiotic mixtures at all time points resulted in a 
greater production of acetate and butyrate compared to a negative control, whereas the 
concentrations of iso-valerate were lower in these three treatments. Lactate 
concentrations were higher only after 8 h of fermentation with maltodextrin, FOS and 
the synbiotic mixtures.  
 
Conclusion: Probiotics alone had no significant effect upon relevant microbial 
populations and SCFA. The effects of synbiotic mixtures on human faecal bacteria were 
similar to FOS as a prebiotic.  
 
 
 
 
Objective 
To study the in vitro fermentation properties of two synbiotic mixtures (FOS + 
Bifidobacterium lactis BB12 and FOS + Bifidobacterium lactis HN019) on human 
faecal bacteria of healthy humans. 
1) Investigate the growth of total bacteria and 11 functionally significant faecal 
microbial groups in a pH-controlled, stirred, batch-culture fermentation system 
reflective of the environmental conditions of the distal region of the human large 
intestine. 
2) Analyse the production of selected short-chain fatty acid (SCFA). 
 
Materials and methods 
Methods 
Substrates 
Fructo-oligosaccharide with a degree of polymerisation < 10 and maltodextrin 
were supplied by University Hospital Southampton NHS Foundation Trust. Freeze-
dried Bifidobacterium animalis subsp. lactis HN019 (DuPont-Danisco, Madison, USA) 
and Bifidobacterium animalis subsp. lactis BB12 (Chr. Hansen, Hørsholm, Denmark) 
were stored at -80 °C. Plates of de Man-Rogosa-Sharpe (MRS) agar (Oxoid Ltd, 
Basingstoke, Hampshire, UK) were inoculated with the bifidobacterial strains and 
incubated at 37°C in an anaerobic chamber (10% CO2, 10% H2 and 80% N2, Don 
Whitley Scientific LTD, Shipley, West Yorkshire, UK). After incubation, bottles 
containing 9 mL of MRS broth were then inoculated with one colony from each plate. 
The cultured broths of probiotics were incubated for 24 h under the same conditions as 
mentioned above. 
 
Faecal sample preparation 
Faecal samples were collected from three separate individuals (2 women and 1 
man aged between 25 and 35y) who were in good health, were not taking probiotic or 
prebiotic supplements and had not had antibiotics for at least 3 months before the study. 
Samples were collected, on site, on the day of the experiment and placed in an 
anaerobic jar (AnaeroJarTM 2.5L, Oxoid Ltd), including a gas-generating kit 
(AnaeroGenTM, Oxoid). Then, samples were weighed, diluted, 1:10 (w/v), with 
anaerobic sterile PBS (0.1 mol/L phosphate buffer solution, pH 7·4) and homogenised 
(Stomacher 400; Seward) for 2 min at 240 paddle/min. Resulting faecal slurries from 
each individual were used to inoculate the batch culture fermentation systems. 
 
In vitro batch culture fermentation 
Sterile stirred batch culture fermentation vessels (300 mL working volume) were 
prepared and aseptically filled with 135 mL of sterile basal nutrient medium (peptone 
water (2 g/l), yeast extract (2 g/l), NaCl (0.1 g/l), K2HPO4 (0.04 g/l), NaCO3 (2 g/l), 
MgSO4.7H2O (0.01 g/l), CaCl2.6H2O (0.01 g/l), Tween 80 (2 ml/l), haemin (50 mg/l), 
vitamin K1 (10 ll/l), L-cysteine (0.5 g/l), bile salts (0.5 g/l), resazurin (1 mg/l) and 
distilled water). Once in the fermentation vessels, sterile medium was maintained under 
anaerobic conditions by sparging the vessels with O2-free N2 overnight. Temperature 
was held at 37 °C using a circulating water bath and pH values controlled between 6.7 
and 6.9 using an automated pH controller (Fermac 260; Electrolab, Tewkesbury, UK) 
which added acid or alkali as required (0.5 M HCl and 0.5 M NaOH). Culture pH and 
temperature mimicked the conditions of the distal region of the human large intestine. 
Seven gently stirred pH-controlled batch fermenters were run in parallel. Two 
vessels were inoculated with the carbohydrates FOS and maltodextrin (1% w/v) and 
another set of two vessels were inoculated with 1 mL of a suspension of B. lactis 
HN019 and B. lactis BB12 (106 CFU mL-1), respectively. The two synbiotic vessels 
were inoculated with FOS combined with B. lactis HN019 and B. lactis BB12 at the 
same concentrations as above. Finally, a control with neither probiotics nor 
carbohydrates added (negative control) was also included.  
The experiment was performed in triplicate, using one faecal sample given by a 
different donor for each run of seven batch fermenters. Probiotics and carbohydrates 
were added to each vessel just before the addition of 15 mL (1:10, w/v) of fresh faecal 
slurry, prepared as described above. Batch cultures were conducted for 48 h, and 4 mL 
samples obtained from each vessel at 0, 8, 24 and 48 h for analysis of bacterial 
populations by fluorescent I situ hybridization (FISH) and for SCFA analyses using gas 
chromatography (GC). 
 
Enumeration of bacterial populations by FISH  
Bacterial composition in the batch culture models was analysed by FISH with 
flow cytometry (FISH-FCM). Seven hundred and fifty microlitres of samples were 
centrifuged at 1136 × g for 5 min. Pellets were resuspended in 375 μL of filtered PBS 
and fixed in 1125 μL of 4% (v/v) paraformaldehyde. After 4 h of incubation at 4◦C, 
samples were washed twice using 1 mL of PBS, resuspended in 600 μL PBS-ethanol 
(1:1, v/v) and stored at –20°C. Permeabilisation steps were performed using 30 μL of 
the fixed samples added to 500 μL PBS and centrifuged at 1136 × g for 3 min. Pellets 
were resuspended using 100 μL of filtered TE-FISH (Tris/HCl 1 M pH 8, EDTA 0.5 M 
pH 8, distilled H2O, 0.22 μm PVDF membrane) containing lysozyme (1 mg/mL of 50 
000 U/mg protein) and incubated for 10 min at room temperature. Solutions containing 
the samples were then vortexed and centrifuged at 1136 × g for 3 min. Pellets were 
washed with 500 μL PBS and centrifuged (1136 × g, 3 min). Hybridisations were 
performed by resuspending the pellets in 150 μL of hybridisation buffer (5 M NaCl, 1 
M Tris/HCl pH 8, 30% formamide, ddH2O, 10% SDS), vortexed and centrifuged (1136 
× g, 3 min). Pellets were then resuspended in 1 mL of hybridisation buffer and 50 μL 
aliquoted into Eppendorf tubes. 
Probes used (Sigma Aldrich Ltd, Poole, Dorset, UK) are shown in Table 1. Four 
microliters of each probe and 4 μL of Eub338 I-II-III were added to the working 
solution and incubated overnight at 35◦C in a heating block. After 12 h of incubation, an 
aliquot of 150 μL hybridisation buffer was added to the working solution, vortexed and 
centrifuged (1136 × g, 3 min). One hundred and fifty microlitres of supernatant was 
removed from each sample and the remaining volume centrifuged (1136 × g, 3 min). 
The pellets were washed with 200 μL of washing buffer (5 M NaCl, 1 M Tris/HCl pH 8, 
0.5 M EDTA pH 8, ddH2O, 10% SDS), homogenised by vortexing and incubated for 20 
min at 37◦C in a heating block. Afterwards, samples were centrifuged (1136 × g, 3 min) 
and supernatants removed. Negative control samples (no probes added) were screened 
by FCM to detect background before the probe samples were resuspended in an 
appropriate amount of PBS. Samples were stored at 4◦C until determination. Numbers 
of specific and total bacteria were assessed taking into account dilution factor, 
calculated from different volumes used in samples preparation steps, and events/μL 
obtained from NON EUB338 and EUB338 I-II-III probes analysed by FCM. 
 
SCFA analysis 
Aliquots of 1 mL of samples supernatant were transferred into glass tubes, 
followed by the addition of 50 μL of internal standard (100 mM; 2-ethylbutyric acid), 
500 μL of concentrated hydrochloric acid (HCl) and 3 mL of diethyl ether (Sigma 
Aldrich Ltd., Poole, Dorset, UK). Samples were then vortexed for 1 min before 
centrifugation at 3,000 x g for 10 min. The top ether layer was transferred from each 
tube into clean glass tubes. A second extraction step was then completed using a further 
1mL of diethyl ether. The diethyl layer was again collected and pooled with the layer 
from the first extraction. Aliquots of 400μL of this pooled extract were transferred into 
glass vials, alongside 50 μL of N-methyl-N-tbutyldimethylsilyltrifluoroacetamide 
(Cheshire Sciences, Chester, UK). Samples were then incubated at 80°C in a water bath 
for 20 min and left at room temperature for 72 h to allow for the complete derivatisation 
of lactic acid.  
The derivatised samples were run on a 5890 Series II Gas Chromatograph (HP, 
Crawley, West Sussex, UK) with flame ionisation detector, using an Rtx-1 
10m×0.18mm column coated with a 0.20μm coating (Crossbond 100% dimethyl 
polysiloxane; Restek, Buckinghamshire, UK). Injector and detector temperature were 
set at 275°C and the column temperature programmed from 63°C for 3 min to 190°C at 
10°C/min-1 and held at 190 °C for 3 min. Helium was used as the carrier gas (flow rate 
1.2 mL/min; head pressure 90 MPa). External standards contained (mM): sodium 
formate, 10; acetic acid, 30; propionic acid, 20; iso-butyric acid, 5; n-butyric acid, 20; 
isovaleric acid, 5; n-valeric acid, 5; sodium lactate, 10; sodium succinate, 20. 
Chemstation B.03.01 (Agilent Technologies, Cheshire, UK) was used for calibration 
and calculation of the internal response factor for quantification of peak areas within 
samples. 
 
Statistical analysis 
One-way ANOVA tests were used to compare treatments data for bacterial counts 
and SCFA concentrations. The data of each treatment were compared over the same 
time of fermentation. Mean values were then analysed using the post hoc analysis 
Tukey test at P ≤ 0.05 by Statistica software version 10.0 (Statsoft South America). 
 
Table 1. Oligonucleotide probes used in this study for FISH-FCM analysis of bacterial 
populations. +: These probes are used together in equimolar concentration of 50 ng/μL. 
Probe name Sequence (5’ TO 3’) Target group 
Non Eub ACTCCTACGGGAGGCAGC  
Eub338 I + GCT GCC TCC CGT AGG AGT Most bacteria 
Eub338 II + GCA GCC ACC CGT AGG TGT Planctomycetales 
Eub338 III + GCT GCC ACC CGT AGG TGT Verrucomicrobiales 
Bif164 CAT CCG GCA TTA CCA CCC Most Bifidobacterium spp. and 
Parascardovia 
denticolens 
Lab158 GGTATTAGCAYCTGTTTCCA Most Lactobacillus, Leuconostoc and 
Weissella spp.; Lactococcus lactis; all 
Vagococcus, Enterococcus, 
Melisococcus, Tetragenococcus, 
Catellicoccus, Pediococcus and 
Paralactobacillus spp, 
Bac303 CCA ATG TGG GGG ACC TT Most Bacteroidaceae and 
Prevotellaceae, some 
Porphyromonadaceae 
Erec482 GCT TCT TAG TCA RGT ACCG Most of the Clostridium coccoides-
Eubacterium rectale group 
(Clostridium clusters XIVa and XIVb) 
Rrec584 TCA GAC TTG CCG YAC CGC Roseburia subcluster 
Ato291 GGT CGG TCT CTC AAC CC Atopobium, Colinsella, Olsenella and 
Eggerthella spp.; Cryptobacterium 
curtum; Mycoplasma equigenitalium 
and Mycoplasma elephantis 
Prop853 ATT GCG TTA ACT CCG GCAC Clostridial cluster IX 
Fprau655 CGCCTACCTCTGCACTAC Faecalibacterium prausnitzii and 
related sequences 
DSV687 TAC GGA TTT CAC TCC T Most Desulfovibrionales (excluding 
Lawsonia) and many 
Desulfuromonales 
Chis150 TTATGCGGTATTAATCTYCCTTT Most of the Clostridium histolyticum 
group (Clostridium clusters I and II) 
CFB286 GTAGGGGTTCTGAGAGGA Cytophaga-Flexibacter-Bacteroides 
Results 
Bacterial Enumeration by FISH  
 
In order to determine bacterial population changes, 16S-rRNA fluorescent in situ 
hybridisation probes were used to follow the changes in population of total bacteria and 
11 functionally significant faecal microbial groups (at 0, 8, 24 and 48 h of incubation). 
Trends to increases in maltodextrin, FOS and both synbiotic vessels were 
observed for total bacterial levels (detected by Eub I-II-III probe), however no 
significant changes were found, the highest number was detected in the fermentation 
with BB12 + FOS at 8 h (Log10 8.34 ± 0.18 bacteria mL
-1).  
A significant increase in Bifidobacterium spp. numbers (detected by Bif164 probe) 
was observed for FOS and synbiotic mixtures compared to probiotic vessels and the 
negative control (P < 0.05). Regarding Lactobacillus-Enterococcus group (detected by 
Lab158 probe), no significant changes were observed at all time points, however, 
highest numbers were detected in the fermentation with FOS at 24 h (Log10 6.24 ± 0.45 
bacteria mL-1).   
Levels of Clostridium coccoides–Eubacterium rectale group (detected by Erec482 
probe) significantly increased (P < 0.05) at 8 and 24 h of fermentation with maltodextrin 
(Log10 6.61±0.23 to 7.63±0.53 bacteria mL
-1). An increase in Atopobium cluster 
(detected by Ato291 probe) was observed with FOS fermentation at 8h (Log10 
5.12±0.59 to 7.02±0.54 bacteria mL-1). Because of high variations between the 
volunteers at 8 and 24 h, the increase in the Atopobium cluster was not significant for 
maltodextrin and synbiotic mixtures compared with 0 h. 
No significant differences were found for the other bacterial groups analysed, 
including Bacteroides spp.-Prevotella group (Bac303 probe), Roseburia genus 
(Rrec584 probe), Clostridial cluster IX populations (Prop853 probe), F. prausnitzii 
group (Fprau655 probe), Desulfovibrio genus (DSV687 probe), Clostridium 
histolyticum group (Chis150 probe) and Cytophaga-Flexibacter-Bacteroides (CFB286 
probe). 
 
 
Figure 1. Total bacterial (A), Bif164 (B), Lab158 (C) and Bac303 (D) changes over time as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean 
values at four time points from three healthy faecal donor’s ± standard deviation. * Mean values were significantly different from 0h fermentation (p<0.05). 
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Figure 2. Erec482 (A), Rrec584 (B), Ato291 (C) and Prop853 (D) changes over time as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean 
values at four time points from three healthy faecal donor’s ± standard deviation. * Mean values were significantly different from 0h fermentation (p<0.05). 
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Figure 3. Fprau655 (A), 
DSV687 (B), Chis150 (C) and CFB286 (D) changes over time as log10 CFU/mL in the 
single stage batch culture as analysed by FISH. Values are mean values at four time points from three healthy faecal donor’s ± standard deviation. * Mean values were 
significantly different from 0h fermentation (p<0.05). 
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SCFA production 
 
SCFAs such as acetic, propionic and butyric acid can affect health positively. 
Folowing administration of all treatments, acetate was the main end product of 
microbial fermentation. Acetate concentrations increased (P < 0.05) on maltodextrin, 
FOS and synbiotic vessels compared to the negative control and the probiotics, however 
there were no significant differences.  
Production of butyrate was also higher (P < 0.05) in the vessels with maltodextrin, 
FOS and synbiotic addition compared to the negative control. Propionate increased in 
all vessels compared with 0 h, however because of high variations between the 
volunteers at 24 and 48 h, the increase of this SCFA with maltodextrin, FOS and 
synbiotic fermentation was not significant compared to the negative control. Lactate 
concentrations were higher only after 8h of fermentation in the vessels containing 
carbohydrates – as it is an electron sink product.  
On the other hand, isovalerate, a branched-chain fatty acids (BCFA) from amino 
acid metabolism was higher in the probiotic vessels and the negative control after 24 
and 48 h of fermentation. The presence of maltodextrin and FOS may have inhibited 
production of this BCFA. No differences were found in valerate or isobutyrate. 
 
 
 
  
 
 
 
  
 
 
 
 
Figure 4. 
Changes 
in Acetate (A), Propionate 
(B), Butyrate (C) and 
Lactate (D) (mM per mL) 
of batch culture sample concentration over time. Values are mean values at four time points from 
three healthy faecal donor’s ± standard deviation. * Mean values were significantly different from 0h fermentation (p<0.05). 
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Figure 5. Changes in 
Isobutyrate (A), Isovalerate (B) and Valerate (C) and Lactate (D) (mM per 
mL) of batch culture sample concentration over time. Values are mean values at four time points from three healthy faecal donor’s ± standard deviation. * Mean values were 
significantly different from 0h fermentation (p<0.05). 
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